HHPR Associate Editor Natalie Wing interviewed Dr. George Molina, MD, MPH, who is a surgical oncologist at the Dana Farber Cancer Institute and at the Brigham and Women’s Center for Surgery and Public Health. He also conducts research in public health regarding access to care and the impact of the surgical safety checklist. He completed a residency program in General Surgery at Massachusetts General Hospital and a two-year post-graduate fellowship at Ariadne Labs. He holds an MPH in Quantitative Methods from the Harvard T.H. Chan School of Public Health, an MD from Harvard Medical School and a BS in Cellular and Molecular Biology from Johns Hopkins University.
Read MoreIn this piece, Professor Carrier explains why legislation addressing product hopping is the best option to address this anticompetitive behavior. He focuses on the Affordable Prescriptions for Patients Act of 2021, bipartisan legislation that addresses the harms from product hopping while appropriately deferring to any reasonable justifications the drug company could offer. He explains how the legislation is conservative in several ways and addresses the industry’s argument that product-hopping legislation harms innovation. And he concludes that legislation can play a crucial role in ensuring that consumers have access to affordable generic medicines.
Read More